2, Aug 2024
Aster DM Healthcare extends support to the victims of the Wayanad Landslide in Kerala
Wayanad, 02 August 2024: In the wake of the devastating landslides that have struck Wayanad, Kerala, Aster DM Healthcare, one of the largest integrated healthcare providers, has stepped forward with profound compassion and support for the affected communities.
Responding swiftly to the disaster, Dr. Moopen’s Medical College (formerly DM Wayanad Institute of Medical Sciences) has mobilised resources in collaboration with government hospitals and Public Health Centres (PHCs) to provide immediate medical care. As of today, 173 people have been admitted, with 62 still under treatment. Seven individuals are in the intensive care unit, and 20 have undergone emergency surgery and are on the path to recovery.
The Kerala State Government has also generously furnished additional medical equipment and other supplies to facilitate efficient treatment. In addition to the tireless efforts of medical and non-medical personnel on the ground, Aster Volunteers have deployed a mobile medical unit and are supplying essential resources—including water, food, and other necessities—to support the National Disaster Response Force (NDRF) in their remarkable efforts.
Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, expressed, “We extend our deepest sympathies to the bereaved families who have lost their loved ones and to the communities grappling with this profound calamity. Our heartfelt thoughts are with all those affected by this devastating disaster. In addition to the on-the-ground efforts that we are making, we have committed Rs. 1.5 crores to the Chief Minister’s Relief Fund and Rs. 2.5 crores towards rebuilding homes for those who are being displaced as a result of the disaster. Furthermore, we will continue to support those affected by the disaster in any way that we can.”
U. Basheer, Executive Trustee, Dr. Moopen’s Medical College, also conveyed his heartfelt appreciation for Aster DM Healthcare’s prompt and substantial support during this crisis.
Aster DM Healthcare remains resolute in its mission to deliver compassionate and comprehensive care during this period of adversity. United in purpose, the organisation is committed to bringing relief and resilience to those in need, confident that their collective efforts will aid in the healing and recovery of the affected communities.
- 0
- By Rabindra
1, Aug 2024
Aster DM Healthcare Q1 FY25 Results
Bengaluru, August 1, 2024: Aster DM Healthcare, one of the leading integrated healthcare service providers in India, today announced its financial results for the quarter ended June 30, 2024.
Key Financial Highlights
- Revenue grew 20% YoY to INR 1,002 Crs. in Q1 FY25 Vs. INR 838 Crs. in Q1 FY24.
- Operating EBITDA grew 39% YoY to INR 177 Crs. in Q1 FY25 Vs. INR 128 Crs. in Q1 FY24.
- Operating EBITDA Margins stood at 17.7% in Q1 FY25 Vs. 15.3% in Q1 FY24
- PBT grew by 125% YoY to INR 123 Crs. in Q1 FY25 Vs. INR 54 Crs. in Q1 FY24.
- Net Profit (post NCI) grew by 80% to INR 74 Crs. in Q1 FY25 Vs. INR 41 Crs. in Q1 FY24.
Commenting on the performance for Q1 FY25, Dr. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “I am pleased to announce that this quarter represents a pivotal moment for Aster DM Healthcare. With the successful segregation of our GCC business, we are now a pure-play India entity, as we embark on a new journey FY25 onwards. In Q1 FY25, our India business achieved 20% YoY growth delivering the highest ever revenue performance of INR 1,002 crores, aided by an increase in bed capacity and growth in ARPOB. The Operating EBITDA grew by 39% YoY to INR 177 crores and net profits (post NCI) grew by 80% YoY to INR 74 crores in Q1 FY25”
Dr. Moopen further added, “Aster DM Healthcare continues to get prestigious recognitions at the national level. Recently, The Economic Times awarded us as the “Best Healthcare Brand of the Year-2024”. Also, Aster CMI Hospital became the first hospital in South India to receive NABH Digital Platinum Accreditation. As we progress, we are on track to reach 6,500+ beds by FY27, further strengthening our position as a leader in the healthcare sector.”
India Performance Highlights
- Core Hospital & Clinics business delivered Operating EBITDA margin of ~21% in Q1 FY25.
- Matured Hospital’s (>6 years since commencement) Operating EBITDA margins at 23.2% in Q1 FY25
- Whitefield hospital (Bangalore) achieved 65% occupancy levels and ARPOB is above INR 70k+ in Q1 FY25
- Payor mix improved with Insurance business at 30% (i.e. +200 bps), offset by lower scheme business.
- Karnataka & Maharashtra cluster revenue grew by 38% YoY and operating EBITDA grew by 55% YoY
- Aster Labs revenue grew by 15% YoY in Q1 FY25, continuing to deliver positive operating EBITDA margin
